Centre International De Recherche SUR LE Cancer
Lyon, Auvergne-Rhône-Alpes Doing business as Iarc
- UEI
- HSMZYXZ7M358
- CAGE
- I9027
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 25 Av. Tony Garnier, 69007 Lyon, France
- Website
- who.int
- Founded
- 1948
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health & Wellness
- SIC code
- 83 Social Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Proteogenomic framework for precision lung cancer screening - project summary lung cancer is the leading cause of cancer… | National Cancer Institute | $546,542 | |
| The opioid cohort consortium (opico) to investigate the effects of using opioids on cancer risk - summary over the… | National Cancer Institute | $5,140,806 | |
| A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and… | National Cancer Institute | $2,995,243 | |
| Intra-tumour heterogeneity of pleural mesothelioma at the single-cell level | Defense Health Agency | $100,000 | |
| The lung early proteins project: a leap toward implementing biomarkers in lung cancer screening - summary: the lung… | National Cancer Institute | $3,086,419 |
About Centre International De Recherche SUR LE Cancer
Centre International De Recherche SUR LE Cancer, doing business as IARC (International Agency for Research on Cancer), is an international organization registered to receive awards from the U.S. federal government since 2003. As the specialized cancer research agency of the World Health Organization, IARC focuses on promoting international collaboration in cancer research, conducting and coordinating research into the causes of cancer, and developing scientific strategies for cancer control. Through federal contract and grant awards, IARC provides a wide range of research services and expertise related to cancer epidemiology, prevention, and control, supporting global efforts to reduce the burden of cancer.
IARC has been awarded several federal contracts, primarily from agencies within the Department of Health and Human Services. The National Cancer Institute has contracted IARC for multiple projects, including support for creating IT and computational environments for cancer research, urine sample retrieval and transfer for cancer studies, and provision of DNA samples and data from cancer patients. The Food and Drug Administration awarded IARC a contract for an international collaboration on cancer classification and research. These contracts, typically in the form of purchase orders, have ranged in value from approximately $13,000 to $60,000. The work performed under these contracts demonstrates IARC's capabilities in managing biospecimens, conducting data analysis, and supporting international cancer research initiatives.
IARC has received numerous federal research grants, showcasing its extensive involvement in cancer research and prevention efforts. Major grant projects include studies on opioid use and cancer risk, development of AI-supported screening and triage systems for cervical cancer, biomarker development for lung cancer risk prediction, and investigations into genetic susceptibility for various cancer types. These grants, primarily funded by the National Cancer Institute, often involve collaborative efforts with other research institutions worldwide. IARC's grant-funded work spans a wide range of cancer-related topics, including genomic studies, biomarker development, risk prediction modeling, and cancer prevention strategies. The organization also receives funding to coordinate large-scale international research consortia and maintain databases crucial for global cancer research efforts. These grants, often multi-year and multi-million dollar awards, highlight IARC's significant role in advancing cancer research and prevention on a global scale.
Quick answers
What is Centre International De Recherche SUR LE Cancer's UEI?
Centre International De Recherche SUR LE Cancer's Unique Entity ID (UEI) in SAM.gov is HSMZYXZ7M358.
What is Centre International De Recherche SUR LE Cancer's CAGE code?
Centre International De Recherche SUR LE Cancer's CAGE code is I9027.
What is Centre International De Recherche SUR LE Cancer's primary NAICS code?
Centre International De Recherche SUR LE Cancer's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Centre International De Recherche SUR LE Cancer located?
Centre International De Recherche SUR LE Cancer's physical address in SAM.gov is 25 Av. Tony Garnier, 69007 Lyon, France.
Is Centre International De Recherche SUR LE Cancer registered in SAM.gov?
Yes. Centre International De Recherche SUR LE Cancer's SAM.gov registration is active through December 8, 2026.
What is Centre International De Recherche SUR LE Cancer's most recent federal award?
Centre International De Recherche SUR LE Cancer's most recent federal grant award is Proteogenomic framework for precision lung cancer screening - project summary lung cancer is the leading cause of cancer… (R01CA316401), from National Cancer Institute, on August 11, 2026.
On GovTribe
See Centre International De Recherche SUR LE Cancer's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors